Environmental conditioning in the control of macrophage thrombospondin-1 production

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Fordham, Jezrom B ^a   Hua, Jing ^a,c   Morwood, Sarah R ^a   Schewitz Bowers, Lauren P ^a   Copland, David A ^a   Dick, Andrew D ^a,b   Nicholson, Lindsay B ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOKINE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL COMMUNICATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; PERITONEAL CAVITY; TH1 CELL; TH2 CELL; UVEITIS;

ADENOSINE; ANIMALS; BONE MARROW CELLS; CELL COMMUNICATION; CYTOKINES; DINOPROSTONE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; PERITONEAL CAVITY; TH1 CELLS; TH2 CELLS; THROMBOSPONDIN 1; TOLL-LIKE RECEPTOR 4; UVEITIS;

EID: 84864147146     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00512     Document Type: Article

References (42)

1. Medzhitov, R. & Horng, T. Transcriptional control of the inflammatory response. Nat Rev Immunol 9, 692-703 (2009).
2. Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12, 231-238 (2011).
3. Desmedt, M., Rottiers, P.,Dooms, H., Fiers, W. & Grooten, J. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. Journal of Immunology 160, 5300-5308 (1998). (Pubitemid 28267817)
4. Fujihara, M. et al. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacology & Therapeutics 100, 171-194 (2003). (Pubitemid 37377912)
5. Zamiri, P.,Masli, S., Kitaichi, N., Taylor, A. W. & Streilein, J. W. Thrombospondin Plays a Vital Role in the Immune Privilege of the Eye. InvestigativeOphthalmology Visual Science 46, 908-919 (2005). (Pubitemid 41321027)
6. Yang, K. et al. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. Journal of Autoimmunity 32, 94-103 (2009).
7. Mansfield, P. J. & Suchard, S. J. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153, 4219-4229 (1994). (Pubitemid 24322589)
8. Mansfield, P. J. & Suchard, S. J. Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil-like HL-60 cells. J Immunol 150, 1959-1970 (1993). (Pubitemid 23129674)
9. Savill, J., Hogg, N., Ren, Y. & Haslett, C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90, 1513-1522 (1992).
10. Lamy, L. et al. Interactions between CD47 and Thrombospondin Reduce Inflammation. Journal of Immunology 178, 5930-5939 (2007). (Pubitemid 46674390)
11. Crawford, S. E. et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93, 1159-1170 (1998). (Pubitemid 28307421)
12. Streit, M. et al. Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas. Am J Pathol 155, 441-452 (1999). (Pubitemid 29370394)
13. Daniel, C., Schaub, K., Amann, K., Lawler, J. & Hugo, C. Thrombospondin-1 Is an Endogenous Activator of TGFb in Experimental Diabetic Nephropathy In Vivo. Diabetes 56, 2982-2989, doi:10.2337/db07-0551 (2007). (Pubitemid 350223633)
14. Lawler, J. et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101, 982-992 (1998). (Pubitemid 28125276)
15. Streit, M. et al. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 19, 3272-3282 (2000). (Pubitemid 30428205)
16. Turpie, B. et al. Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. American Journal of Pathology 175, 1136-1147 (2009).
17. Cursiefen, C. et al. Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis. Investigative Ophthalmology & Visual Science 45, 1117-1124, doi:10.1167/iovs.03-0940 (2004). (Pubitemid 38869016)
18. Chen, M. et al. Persistent Inflammation Subverts Thrombospondin-1-Induced Regulation of Retinal Angiogenesis and Is Driven by CCR2 Ligation. The American journal of pathology 180, 235-245 (2012).
19. Masli, S., Turpie, B. & Streilein, J. W. Thrombospondin orchestrates the tolerancepromoting properties of TGFb-treated antigen-presenting cells. International Immunology 18, 689-699 (2006). (Pubitemid 43779059)
20. Jaffe, E. A., Ruggiero, J. T. & Falcone, D. J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65, 79-84 (1985). (Pubitemid 15191041)
21. Dipietro, L. A. & Polverini, P. J. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin-1. American Journal of Pathology 143, 678-684 (1993). (Pubitemid 24058225)
22. Zhang, Q. et al. Bacterial lipoproteins differentially regulate human primary and memory CD41T and B cell responses to pneumococcal protein antigens through Toll-like receptor 2. Journal of Infectious Diseases 201, 1753-1763 (2010).
23. Kuchroo, V. K., Sarvetnick, N., Hafler, D. A. & Nicholson, L. B. Cytokines and Autoimmune Diseases. Vol. 1st (Humana Press, 2002).
24. Adams, J. C. & Lawler, J. The thrombospondins. Int J Biochem Cell Biol 36, 961-968 (2004). (Pubitemid 38528716)
25. Nicholson, L. B., Raveney, B. J. E. & Munder, M. Monocyte Dependent Regulation of Autoimmune Inflammation. Current Molecular Medicine 9, 23-29 (2009).
26. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969 (2008).
27. Calder, C. J., Nicholson, L. B. & Dick, A. D. A selective role for the TNFp55 receptor in autocrine signalling following IFN-gamma stimulation in Experimental Autoimmune Uveoretinitis. Journal of Immunology 175, 6286-6293 (2005). (Pubitemid 41598867)
28. Kerr, E. C., Copland, D. A., Dick, A. D. & Nicholson, L. B. The Dynamics of Leukocyte Infiltration in Experimental Autoimmune Uveoretinitis. Progress in Retinal and Eye Research 27, 527-535 (2008).
29. Li, S. S. et al. T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components. Eur J Immunol 32, 1069-1079 (2002). (Pubitemid 34428823)
30. Li, S. S., Liu, Z., Uzunel,M. & Sundqvist, K.-G. Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion. Blood 108, 3112-3120 (2006).
31. Rosenbaum, J. T., McDevitt, H. O., Guss, R. B. & Egbert, P. R. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286, 611-613 (1980). (Pubitemid 10015368)
32. Forrester, J. V.,Worgul, B. V. & Merriam, G. R., Jr. Endotoxin-induced uveitis in the rat. Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie 213, 221-233 (1980). (Pubitemid 10073225)
33. Bettelli, E., Korn, T. & Kuchroo, V. K. Th17: the third member of the effector T cell trilogy. Current Opinion in Immunology 19, 652-657, doi:DOI: 10.1016/ j.coi.2007.07.020 (2007). (Pubitemid 350236805)
34. Morwood, S. R. & Nicholson, L. B. Modulation of the immune response by extracellular matrix proteins. Archivum Immunologiae et Therapiae Experimentalis 54, 1-8 (2006).
35. Saban, D. R., Bock, F., Chauhan, S. K., Masli, S. & Dana, R. Thrombospondin-1 Derived from APCs Regulates Their Capacity for Allosensitization. The Journal of Immunology 185, 4691-4697, doi:10.4049/jimmunol.1001133 (2010).
36. Jones, L. S. et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. Journal of Immunology 158, 5997-6005 (1997). (Pubitemid 127484009)
37. Krakowski, M. & Owens, T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology 26, 1641-1646 (1996). (Pubitemid 26230015)
38. Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12, 255-263 (2011).
39. Luger, D. et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. Journal of Experimental Medicine 205, 799-810 (2008). (Pubitemid 351549879)
40. Munder, P. G., Modolell, M. & Wallach, D. F. Cell propagation on films of polymeric flurocarbon as ameans to regulate pericellular pH and pO2 in cultured monolayers. FEBS letters 15, 191-196 (1971).
41. Cox, C. A. et al. Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities. The Journal of Immunology 180, 7414-7422 (2008).
42. Kerr, E. C., Raveney, B. J. E., Copland, D. A., Dick, A. D. & Nicholson, L. B. Analysis of Retinal Cellular Infiltrate in Experimental Autoimmune Uveoretinitis Reveals Multiple Regulatory Cell Populations. Journal of Autoimmunity 31, 354-361 (2008).